Trump push to combat drug trade may mean starting with
Trump push to combat drug trade may mean starting with China, not Mexico
If President-elect Donald Trump wants to fulfill his campaign promise of stemming the flow of drugs coming across the United States’ border with Mexico, he may want to start by looking at China.
Manufacturers and organized crime groups in the world’s most populous country are responsible for the majority of fentanyl -- the synthetic opioid that is 50 times more potent than heroin -- that ends up in the U.S. and the majority of precursor chemicals used by Mexican drug cartels to make methamphetamine, according to numerous published U.S. government reports.
“The Mexican cartels are buying large quantities of fentanyl from China,” Barbara Carreno, a spokesperson with the U.S. Drug Enforcement Administration (DEA), told FoxNews.com. “It’s much easier to produce than waiting around to grow poppies for heroin and it’s incredibly profitable.
The DEA estimates that a kilogram of fentanyl, which sells for between $2,500 and $5,000 in China, can be sold to wholesale drug dealers in the U.S. for as much as $1.5 million and that the demand for the drug due to the prescription opioid crisis in places like New England and the Midwest have kept the prices high.
Trump, along with numerous other presidential hopefuls, promised while on the stump in states hard-hit by drug addiction to quickly tackle the widespread use of drugs like fentanyl and heroin. While heroin addiction has been a concern for decades, in recent years the number of users of heroin and fentanyl -- and its more potent derivatives like carfentanil -- has skyrocketed as the government clamps down on the abuse of prescription opioids like OxyContin and Percocet.
"We're going to build that wall and we're going to stop that heroin from pouring in and we're going to stop the poison of the youth," Trump said during a September campaign stop in New Hampshire.
The problem with cracking down on fentanyl and its derivatives is that while these substances may be banned in the U.S., they may not be illegal in their country of origin. China, for example, only last year added 116 synthetic drugs to its controlled substances list, but failed to include carfentanil – a drug that is 10,000 times more potent than morphine and has been researched as a chemical weapon by the U.S., U.K., Russia, Israel, China, the Czech Republic and India.
“It can kill you if just a few grains gets absorbed through the skin,” Carreno said.
While Mexican cartels obtain these substances in large quantities through the murky backwaters of the Chinese black market, anybody with a credit card and Internet access can call one of the numerous companies in China’s freewheeling pharmaceutical industry that manufactures fentanyl and its more potent cousins.
Earlier this year, The Associated Press found at least 12 Chinese businesses that said they would export carfentanil to the United States, Canada, the United Kingdom, France, Germany, Belgium and Australia for as little as $2,750 a kilogram.
Besides synthetic opioids, Chinese companies are also producing massive amounts of the precursor chemicals used to make methamphetamine.
As the methamphetamine industry evolved over the last decade or so from small, homegrown operations in the U.S. to the super-labs run by Mexican cartels, cooks and producers of the drug have begun to rely more and more on China for their ingredients. Mexico now supplies 90 percent of the methamphetamine found in the U.S., and 80 percent of precursor chemicals used in Mexican meth come from China, according to a study by the U.S.-China Economic and Security Review Commission.
“China is the major source for precursor chemicals going to Mexico,” David Shirk, a global fellow at the Washington, D.C.-based Woodrow Wilson International Center for Scholars, told FoxNews.com. “The problem is finding who the connection is between organized crime groups in China and organized crime groups in Mexico.”
Shirk added that law enforcement and drug war experts generally have a good picture of the major players in Mexican organized crime, but the Chinese underworld is less well mapped and it is more difficult to pin down the major players in the drug trade there.
Despite U.S. efforts to crackdown on both the fentanyl and methamphetamine trades, U.S. government officials acknowledge that much of the onus lies with the Chinese. Chinese state officials take allegations of drug-related corruption seriously, launching investigations when deemed appropriate, but a U.S. State Department report found that drug-related corruption among local and lower-level government officials continues to be a concern.
When he takes office in January, Trump has a few things working in his favor in respect to combatting the drug trade.
One is the continued fracturing of some of Mexico’s largest and most powerful drug cartels. The Sinaloa Cartel, for example, was seen for years as an impenetrable drug organization until cracks began to appear in its armor following the re-arrest earlier this year of its leader, Joaquín “El Chapo” Guzmán, and the power struggle that ensued.
“When the violence goes up, business always goes down,” Shirk said.
Another factor that will help Trump’s war on drugs is U.S. anti-drug officials claim that their work in collusion with their Chinese counterparts is already helping greatly. Six months after China added a slew of synthetic drugs to its controlled substances list, monthly seizures in the U.S. of acetylfentanyl -- a weak variant of fentanyl -- were down 60 percent, the DEA reported.
“We’re continuing to work with the Chinese to see if they might control more of these substances,” Carreno said. “When they put controls on these substances it makes a huge difference.”
1
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...
Continue Reading
Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...
Continue Reading
A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...
Continue Reading
Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...
Continue Reading
Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...
Continue Reading
Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...
Continue Reading
A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...
Continue Reading
Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...
Continue Reading
Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...
Continue Reading
Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...
Continue Reading
Top 5 Most Recently Viewed Articles
Pan Global Resources Making Waves in Spain Pan Global Resources Inc. (TSXV: PGZ | OTCQX: PGZFF | FRA: 2EU) is currently marking a pivotal phase in its operations, focusing on two notable projects located in Spain: Escacena and Cármenes. The company has reported impressive results from its exploration programs throughout the year, indicating significant growth potential...
Continue Reading
Introducing the Hazelview Cares Foundation Hazelview Investments is excited to announce the establishment of the Hazelview Cares Foundation, which aims to enhance and uplift the communities where it operates. This not-for-profit organization focuses on creating opportunities for individuals and families to thrive, ensuring that everyone has the potential to achieve their...
Continue Reading
Merritt Properties Approaches Full Occupancy Merritt Properties is excited to announce that its North Chapel Business Center is close to achieving full occupancy, with only 3,600 square feet of space remaining. A major milestone has been reached with the Chapel Hill Police Department committing to a lease of 58,000 square feet for a new headquarters, which is set to open...
Continue Reading
Analyzing Short Interest Trends for TJX Companies TJX Companies (NYSE: TJX) is seeing a notable decline in its short percent of float, which has recently fallen by 9.3%. The latest figures indicate that there are 13.22 million shares sold short, accounting for 1.17% of the total regular shares available for trading. With the current trading volume, it is estimated that...
Continue Reading
Jet.AI Stock Hits 52-Week Low In a challenging market landscape, Jet.AI's stock has recently hit a 52-week low of just $0.08. This dramatic decrease in stock value signals a broader trend of caution among investors, as Jet.AI navigates through a multitude of internal and external challenges. Over the last year, the stock has seen a staggering decline, reflecting a 97.19%...
Continue Reading